Articles by Niamh Madigan
|
|
|
Niamh Madigan is Editor of Pharma IQ and has worked at IQPC since 2008, initially as a Conference Producer on Pharmaceutical and Shared Services & Outsourcing events. Due to her journalistic experience, Niamh moved on to work as an Online Editor for the Shared Services and Outsourcing Network, prior to moving back to the Pharmaceuticals division. Niamh has used her combined experience as journalist and events manager to produce and host online learning forums such as webinars and Online conferences for IQPC. Niamh’s journalistic career began in Ireland where she worked for the National Broadcaster, RTE, as a Television Producer on current affairs and health programmes for 5 years. She holds a BA (Hons) in Media Studies and a First PostGraduate Diploma in Journalism.
-
Pharma IQ has put together a list of 8 regulations and guidelines that look set to impact different divisions of the pharma and biotech industry in 2013. ONE: Good Distribution Practice (GDP) 2013 The revised European Commission Guidelines on the distribution of medicinal products in the EU will come into force in September 2013. Good distribution practice (GDP) ensures...Full Article »
The current Clinical Research Organisation (CRO) landscape is vast, with offerings from functional to full service CROs. Using a CRO’s expertise can maximise the efficiency of your clinical trials, but only if you choose the right one for the project at hand. In a vast and competitive landscape, selecting a CRO is not an easy task. Do you go with a big and established CRO, or an...Full Article »
Last year Pharma IQ put together a list of the TOP 10 pharmaceutical industry associations. As it got a lot of you commenting, we decided to repeat and update it for 2013 with two new worthy entrants! We have broken the list down into industry categories to help you identify the associations which are linked with your area in the industry. The Full Spectrum DIA is a neutral,...Full Article »
Last week the media once again glared into the world of disgraced cyclist, Lance Armstrong, after his admission on the Oprah Winfrey Show that he did in fact take unauthorised substances throughout his cycling career and more specifically in the 7 Tour de France tournaments he competed in and won. The BBC also stated that “the American cyclist revealed he took...Full Article »
While reflecting on the meaning of thanksgiving, Pharma IQ looks back to the time of the 13 colonies where diseases like smallpox, plague and yellow fever meant short lives for the pilgrims living there . Here are 5 facts of medical practices at that time we’d like to share. While there’s much we can thank medicine for today, we continue to look for cures to many untreatable...Full Article »
So Barack Obama has secured another term of office in the US and I’m sure it will be the main topic of conversation around the water cooler today. Even though he is the US president, globally we will all be affected in some way by the decisions he makes and his next four years in the Whitehouse, apart from if you live in Germany! But I like Barack and we actually have a...Full Article »
As the clean-up operations continue after the destruction caused by Hurricane Sandy – industries will be brushing themselves down and assessing how they survived the fiercest Hurricane that the US East Coast has ever seen. And as the globe now operates like a small country village, industries will also realise that the effects of the storm will not just be limited to the East...Full Article »
e-patient : meaning (also known as Internet patient, or Internet-savvy patient) is a health consumer who uses the Internet to gather information about a medical condition of particular interest to them, and who uses electronic communication tools (including Web 2.0 tools) in coping with medical conditions. (Taken from Wikipedia ) This week, we read that a new online tool, has been launched...Full Article »
Pfizer and Johnson & Johnson recently announced that they were going to stop the development of the Alzheimer’s drug, Bapineuzumab, which was designed to halt build-up of plaque in the brain of patients, because it failed in two late-stage clinical trials. It also failed to improve cognitive or functional performance compared with a placebo in certain patients . In assocication...Full Article »
We may be stuck in a recession, but the pharmaceutical industry continues to grow. So which organisations are announcing new plant investments and recruitment? Pharma IQ did a bit of research and looked at the top 10 biggest pharmaceutical organisations, as recognised by Fortune 500 in 2012, to see where the new jobs and opportunities are emerging and on the...Full Article »
Pharma IQ had a quick ring around with some of our trusted experts who are working in clinical trials to get an overview on current and emerging trends in clinical trial supply. This panel of experts included, Robert Bronstein, Director - Clinical Supply Operations, MacroGenics; Robert Smith, Clinical Trials Expert and Steven A. Jacobs, MBA, R.Ph.President, Global BioPharm Solutions, LLC....Full Article »
13 column results Events of Interest-
Compound Management & Integrity Online 2011
November 14, 2011
Register Now -
Regenerative Medicine and Barriers to Commercialisation Online Summit 2011
October 25, 2011
Register Now -
Electronic Laboratory Notebooks Online
December 2, 2011
Register Now -
Drive Successful Commercial Product Launches through Effective Key Packaging
February 7, 2013
Register Now
| 13 column results |
|





Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!